Leronlimab Promising Results For Critical COVID Patients

Please read and agree to the disclaimer before watching this video.
. Leronlimab Promising Results For Critical COVID Patients

Leronlimab CD12 trial results for a sub-population of the patients that are either on mechanical ventilation or ECMO are quite promising. Let’s review the results.

Buy me a coffee :-) https://www.buymeacoffee.com/DrMobeenSyed
Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true
Looking to support my educational work? Donate here: https://paypal.me/mobeensyed?locale.x=en_US
April 01 2021
CytoDyn Files New Protocol with U.S. FDA for 4 Doses of Leronlimab for Critically Ill COVID-19 Patients with the Objective to Duplicate or Surpass 82% Survival Benefit with P-Value of 0.0233 Originally Achieved from Two Weeks of Treatment in CD12 Trial With 2 Doses
https://www.cytodyn.com/newsroom/press-releases/detail/513/cytodyn-files-new-protocol-with-u-s-fda-for-4-doses-of

March 30 2021
CytoDyn’s Leronlimab Decreased Mortality at 14 Days by 82% With Statistically Significant P-Value of 0.0233 Amongst Critically Ill COVID-19 Patients
https://www.cytodyn.com/newsroom/press-releases/detail/512/cytodyns-leronlimab-decreased-mortality-at-14-days-by

March 29th 2021
The Philippines FDA Approves the Use of Leronlimab to Treat a COVID-19 Patient
https://www.globenewswire.com/news-release/2021/03/29/2200553/19782/en/The-Philippines-FDA-Approves-the-Use-of-Leronlimab-to-Treat-a-COVID-19-Patient.html

March 8 2021
CytoDyn to Release CD12 Trial Detailed Results via Form 8-K After Investment Community Webcast, Monday, March 8
https://www.cytodyn.com/newsroom/press-releases/detail/506/cytodyn-to-release-cd12-trial-detailed-results-via-form-8-k

March 8 2021
A critical commentary on Leronlimab results
CytoDyn tries to squeeze positive news out of a failed Covid-19 study — and shares take a beating
https://endpts.com/cytodyn-tries-to-squeeze-positive-news-out-of-a-failed-covid-19-study-and-shares-take-a-beating/
References:
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01726-3
https://www.kpcnews.com/covid-19/article_8ab408ad-8fb0-5f74-8d57-11e586bd8a4f.html
https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html

#drbeen #koolbeens #COVID ...

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional. ...
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.

Видео Leronlimab Promising Results For Critical COVID Patients канала Drbeen Medical Lectures